Keytruda Injection | Pembrolizumab | Immunotherapy | Oncology Medicine Supplier Keytruda Injection contains Pembrolizumab, a monoclonal antibody used in cancer immunotherapy. It works by blocking the PD-1 pathway, helping the immune system recognize and attack cancer cells under medical supervision. 🔍 Keywords Pembrolizumab Injection, Keytruda Supplier, Immunotherapy Drug, PD-1 Inhibitor, Cancer Treatment Medicine, Oncology Injection Exporter 🔹 Product Category Oncology Medicine | Immunotherapy | Monoclonal Antibody 🔹 Composition Pembrolizumab (strength as per COA) 🔹 Uses / Indications ✔ Non-Small Cell Lung Cancer (NSCLC) ✔ Melanoma ✔ Head and Neck Cancer ✔ Urothelial carcinoma ✔ Other cancers (as prescribed) 🔹 Key Benefits ✔ Enhances immune response against cancer ✔ Targeted immunotherapy approach ✔ Improves survival outcomes ✔ Widely used in advanced oncology 🔹 Dosage & Administration ✔ Intravenous infusion ✔ Administered under oncologist supervision ✔ Dosage as per treatment protocol 🔹 Packaging & Supply ✔ Vial Injection ✔ Cold-chain export packaging available ✔ Bulk supply supported 🔹 Storage Instructions ✔ Store at 2–8°C ✔ Do not freeze ✔ Protect from light 🔹 Certifications ✔ WHO-GMP Certified ✔ COA & COPP Available 🌍 Global Export Supply USA, UK, UAE, Singapore, India, Philippines, Vietnam, South Africa, Nigeria, Kenya, Brazil, Mexico, Peru 📍 Location: Nagpur, Maharashtra, India 📞 Contact for Bulk Orders +91 8007161282 +91 9970011496 📧 Email: sales@pacificmedicines.com 🔖 Hashtags #Pembrolizumab #Keytruda #Immunotherapy #CancerTreatment #Oncol